Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

It could have been us...
Still preclinical, but BMY will take a stake in the company. Trains are passing us at a full speed, and we are stuck somewhere on tracks.
#Sad

https://www.businesswire.com/news/home/20181209005013/en/Bristol-Myers-Squibb-Vedanta-Biosciences-Announce-New-Clinical

NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Vedanta Biosciences today announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo in combination with Vedanta Biosciences’ VE800, a rationally-defined human bacterial consortium, in patients with advanced or metastatic cancers.
In conjunction with this collaboration, and subject to the completion of due diligence, the negotiation by the parties of definitive transaction agreements and the receipt by Bristol-Myers Squibb of all requisite approvals, Bristol-Myers Squibb currently intends to make an equity investment in Vedanta Biosciences. Vedanta Biosciences will maintain control of its VE800 program, including global R&D and commercial rights.